Mabuchi S

ORCID: 0000-0003-1803-1166 · 9 papers in corpus
case-report 2025
Cureus ·doi:10.7759/cureus.84391

Parasitic leiomyomas are rare complications of uterine morcellation after laparoscopic hysterectomy (LH). These tumors typically consist of smooth muscle cells and are often asymptomatic. However, parasitic leiomyomas containing endometrial…

review 2024
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15955

Seromucinous borderline tumors (SMBT) are papillary neoplasms without invasive capabilities. Originally categorized as ovarian tumors, SMBT, being an endometriosis-related tumor, can manifest beyond the ovaries. To date, only four cases of …

case-report 2024
Cureus ·doi:10.7759/cureus.74539

Low-grade endometrial stromal sarcoma (LGESS) is a rare disease, accounting for less than 1% of all uterine malignancies. Standard treatment is total hysterectomy and bilateral tubal oophorectomy, although fertility preservation may be desi…

case-report 2022
Gynecologic oncology reports ·doi:10.1016/j.gore.2022.101051

Herlyn-Werner-Wunderlich syndrome (HWWS) is a rare congenital urogenital anomaly characterized by uterine didelphys, unilateral blind hemivagina, and ipsilateral renal agenesis. We present a very rare case of HWWS-associated cervical cancer…

review 2022
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina58050581

Primary fallopian tube carcinoma (PFTC) has characteristics similar to those of ovarian carcinoma. The typical course of PFTC metastasis includes peritoneal dissemination and pelvic and paraaortic lymph node metastasis, while inguinal lymph…

rct 2022
BMC women's health ·doi:10.1186/s12905-022-01824-9

BACKGROUND: Preoperative anemia affects perioperative outcomes and often causes fatigue and psychological disorders. Therefore, anemia should be treated before a patient undergoes surgery. Ninjin'yoeito (NYT), a Japanese Kampo medicine comp…

review 2016
Journal of gynecologic oncology ·doi:10.3802/jgo.2016.27.e31

Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma or endometrioid adenocarcinoma. To improve the sur…

lab-animal 2010
Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-10-0169

This study examines the role of vascular endothelial growth factor (VEGF) as a therapeutic target in clear cell carcinoma (CCC) of the ovary, which has been regarded as a chemoresistant histologic subtype. Immunohistochemical analysis using…

lab-animal 2009
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-09-0365

PURPOSE: Mammalian target of rapamycin (mTOR) plays a central role in cell proliferation and is regarded as a promising target in cancer therapy, including for ovarian cancer. This study aimed to examine the role of mTOR as a therapeutic ta…